|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||
| Current assets: | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Marketable debt securities | |||||||||||||
| Other current assets | |||||||||||||
| Prepaid expenses and other current assets | |||||||||||||
| Total current assets | |||||||||||||
| Right-of-use asset, net | |||||||||||||
| Other assets | |||||||||||||
| Total assets | |||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||||
| Current liabilities: | |||||||||||||
| Accounts payable | |||||||||||||
| Accrued expenses | |||||||||||||
| Lease liability, current portion | |||||||||||||
| Convertible note and accrued interest | |||||||||||||
| Total current liabilities | |||||||||||||
| Long-term lease liability | |||||||||||||
| Other long-term liabilities | |||||||||||||
| Related Party | |||||||||||||
| Total other long-term liabilities | |||||||||||||
| Lease liability, long-term portion | |||||||||||||
| Total liabilities | |||||||||||||
| Series A redeemable convertible preferred stock, par value $.0001. Authorized, issued, and outstanding shares of none and 5,000,000 as of December 31, 2023 and 2022, respectively. | |||||||||||||
| Stockholders' equity: | |||||||||||||
| Preferred stock, par value $0.0001. Authorized shares of 15,000,000. None issued and outstanding as of both June 30, 2026 and December 31, 2025. | |||||||||||||
| Series B Convertible Preferred | |||||||||||||
| Series C Convertible Preferred | |||||||||||||
| Total preferred stock, par value $0.0001. Authorized shares of 15,000,000. None issued and outstanding as of both June 30, 2026 and December 31, 2025. | |||||||||||||
| Common stock, par value $0.0001. Authorized shares of 135,000,000. Issued and outstanding shares of 2,945,552 and 2,524,475 as of June 30, 2026 and December 31, 2025, respectively. | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total stockholders’ equity | |||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||
Loading...
